Flexion Therapeutics Inc (FLXN) Stock
FLXN is no longer traded. Flexion Therapeutics was delisted from the Nasdaq in November 2021.
Prices on this page are historical; the last trade was November 18, 2021 at $9.12.
Flexion Therapeutics stock price history
FLXN final trading statistics
- Final close
- $9.12
- Final trading day
- Nov 18, 2021
- Market cap at delisting
- $458.93M
- Shares outstanding
- 50.32M
- Final 52-week range
- $4.30 – $13.66
- Avg. volume (final 3 mo.)
- 2,378,767
- All-time high (split-adj.)
- $29.93 · Oct 2017
- All-time low (split-adj.)
- $4.40 · Aug 2021
- Return since IPO
- -38.0%
- Beta
- 1.53
- Book value / share
- $0.34
- Price / book
- 27.22
Flexion Therapeutics annual financials
| Fiscal year | Revenue | Net income | EPS |
|---|---|---|---|
| FY2020 | $85.55M | -$113.7M | -$2.53 |
| FY2019 | $72.96M | -$149.8M | -$3.92 |
| FY2018 | $22.52M | -$169.7M | -$4.48 |
| FY2017 | $355.0K | -$137.5M | -$4.16 |
| FY2016 | $0.00 | -$71.9M | -$2.84 |
Last five fiscal years reported before the delisting; fiscal year ending December. EPS is adjusted (non-GAAP) EPS as reported. Source: company filings via EODHD.
About Flexion Therapeutics Inc
Flexion Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies for the treatment of patients with musculoskeletal conditions in the United States. The company offers ZILRETTA, an intra-articular injection for the management of osteoarthritis (OA) knee pain. It is also involved in the development of FX201, a gene therapy product candidate designed to provide on demand production of an anti-inflammatory protein, interleukin-1 receptor antagonist for pain relief from OA of the knee; and FX301, a NaV1.7 inhibitor for the management of post-operative pain. The company was founded in 2007 and is headquartered in Burlington, Massachusetts. As of November 19, 2021, Flexion Therapeutics, Inc. operates as a subsidiary of Pacira BioSciences, Inc..
Flexion Therapeutics stock FAQ
What happened to Flexion Therapeutics stock?
Flexion Therapeutics stock was delisted from the Nasdaq. Its final close was $9.12 on November 18, 2021.
Is FLXN stock still trading?
No. FLXN was delisted from the Nasdaq in November 2021 and no longer trades on a U.S. exchange.
What was the last price of FLXN stock?
FLXN closed at $9.12 on its final trading day, November 18, 2021, for a market value of about $458.93M.
What were Flexion Therapeutics's revenue and earnings in its last full fiscal year?
Flexion Therapeutics reported revenue of $85.55M and net income of -$113.7M in fiscal 2020, its last full year as a public company.
When did Flexion Therapeutics go public?
Flexion Therapeutics Inc stock began trading on February 12, 2014.